-
Sector Analysis
EpiCast Report: Ovarian and Primary Peritoneal Cancer – Epidemiology Forecast to 2025
Ovarian cancer (OC; International Classification of Diseases, Revision 10 [ICD-10] code: C56) and cancer of the fallopian tubes and other uterine adnexa (ICD-10: C57) are leading causes of cancer mortality in women. Cancer of the ovary, fallopian tubes, and other uterine adnexa are collectively referred to as OC throughout this report. In the US, the American Cancer Society reports that OC accounts for more deaths than any other cancer of the female reproductive system. GlobalData epidemiologists forecast the diagnosed incident...
-
Sector Analysis
EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2025
Bladder cancer is a commonly diagnosed cancer and causes significant numbers of cancer deaths worldwide. The major risk factors for bladder cancer are exposure to smoking and occupational risk factors such as exposure to aromatic amines. These risk factors are more prevalent among men, which makes the disease significantly more common in men than women. The majority of bladder cancer cases are among older individuals, with the median age at diagnosis being 73 years; because of this, the comorbidities associated...
-
Product Insights
Hematological Tumor Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Hematological Tumor Global Clinical Trials Review, H2, 2016" provides an overview of Hematological Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on Hematological Tumor. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Anaplastic Thyroid Cancer Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Anaplastic Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Anaplastic Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Anaplastic Thyroid Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Angiosarcoma Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Angiosarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Angiosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Angiosarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Follicular Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Follicular Thyroid Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Intestinal Cancer Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Intestinal Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Intestinal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Intestinal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Pediatric Cancer Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Pediatric Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Pediatric Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pediatric Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Round Cell Liposarcoma Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Round Cell Liposarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Round Cell Liposarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Round Cell Liposarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Pilocytic Astrocytoma Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Pilocytic Astrocytoma Global Clinical Trials Review, H2, 2016" provides an overview of Pilocytic Astrocytoma clinical trials scenario. This report provides top line data relating to the clinical trials on Pilocytic Astrocytoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.